Peringkat dalam Saham
#18684
Founded in 2014 and headquartered in Taipei, Taiwan, AnnJi Pharmaceutical Co.,... Founded in 2014 and headquartered in Taipei, Taiwan, AnnJi Pharmaceutical Co., Ltd. specializes in the creation of innovative medicinal treatments. The company's research and development pipeline addresses neurological, dermatological, and inflammatory conditions. Among its key therapeutic candidates are AJ201, which is being developed for the neurodegenerative disorder spinal and bulbar muscular atrophy, and AJ202, targeting androgenetic alopecia. AnnJi also works on AJ302, a histone deacetylase 6 inhibitor aimed at preventing and treating chemotherapy-induced peripheral neuropathy, and AJ303, an anti-fibrotic and anti-inflammatory agent intended for idiopathic pulmonary fibrosis and other fibrotic diseases.
Kapitalisasi Pasar
$190.02M
Perubahan (1 tahun)
24.67%
Harga 7754 dengan kapitalisasi pasar B
Kapitalisasi pasar dari AnnJi(7754)
Kapitalisasi Pasar: $190.02M
Per August 2026, AnnJi memiliki kapitalisasi pasar sebesar $190.02M. Ini menjadikan AnnJi sebagai perusahaan 18684th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar AnnJi dari 2024 hingga 2026
7754 dibandingkan dengan 5 teratas stocks paling populer
| Harga 7754 |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.088T
|
+2,677,469.31%
|
|
|
|
|
$4.629T
|
+2,436,031.13%
|
|
|
|
|
$4.118T
|
+2,166,847.77%
|
|
|
|
|
$3.687T
|
+1,940,090.74%
|
|
|
|
|
$2.800T
|
+1,473,256.78%
|
